Market Size of Europe Advanced Wound Care Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 6.10 % |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Advanced Wound Care Market Analysis
The European advanced wound care market is expected to register a healthy CAGR of nearly 6.1% during the forecast period of 2022-2027.
The COVID-19 pandemic was expected to have a significant impact on the market. A study titled "Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data", published in December 2020, reported that the new coronavirus strain almost tripled its number of infections in England. Hence, the United Kingdom and many other countries in Europe were seeing localized lockdowns, with Governments imposing travel restrictions, etc. With the lockdown being imposed, elective surgeries were held up again, which was expected to have a negative impact on the market. Governments have taken various definite measures to provide proper wound care management for the population. For instance, a research paper named "Wound Antiseptics and European Guidelines for Antiseptic Application in Wound Treatment" released in December 2021 noted that chronic wound infections afflict roughly 1.5% of the population and that problems with wound healing are highly prevalent. Antiseptics are the primary materials used in wound washing, cleaning, and therapy. Only the following antiseptics should be considered for wound treatment, according to the recommendations of the Polish Society for Wound Treatment and the German Consensus on Wound Antisepsis: octenidine (OCT), polihexanide (PHMB), povidone-iodine (PVP-I), sodium hypochlorite (NaOCl), and nanosilver. Such instances are expected to support the European advanced wound care market during the COVID-19 pandemic.
The major factors that are expected to drive the European advanced wound care market's growth include the high and increasing burden of chronic diseases, a high number of surgeries, and a rising geriatric population along with other risk factors. For instance, according to an article published in June 2021, titled "German Heart Surgery Report 2020: The Annual Updated Registry of the German Society for Thoracic and Cardiovascular Surgery," there were approximately 29,444 isolated coronary artery bypass grafting procedures, 35,469 isolated heart valve procedures, and 843 assist device implantations (including left/right/biventricular assist devices, total artificial devices) registered in Germany. According to the same source, the number of solitary heart transplants in Germany has surged to 340, a 2.1% increase over the previous year. Hence, an increasing number of surgeries are expected to play a significant role in the European advanced wound care market over the forecast period. In addition, according to the International Diabetes Federation in 2021 report, the estimated prevalence of diabetes in adults of age 20-79 years in Europe was 61.4 million in 2021, and this prevalence is projected to reach 69 million by 2045. The increasing incidences of diabetes may further lead to growth in this market because diabetes slows down the healing process making diabetic people more prone to infections and other complications.
Furthermore, the companies operating in the advanced wound care market in Europe are progressive and continuously innovating their products and launching them in the market which is further expected to augment the growth of the studied market. For instance, in November 2020, Advanced Medical Solutions, a surgical and advanced wound care specialist company based in the United Kingdom, received a Conformitè Europëenne (CE) mark for its product 'Silicone PHMB Foam Dressing.' In June 2021, RLS Global, a medical healthcare company based in Sweden, and ConvaTec signed a global collaboration agreement to commercialize ChloraSolv which will be included in ConvaTec's Wound Hygiene Protocol of care for hard-to-heal wounds. Hence, such product launches are expected to drive the market. Thus, the abovementioned factors are anticipated to fuel growth in the advanced wound care market in Europe. However, the high cost associated with the treatment and reimbursement issues for the new technologies is the major factors that are expected to impede the market's growth over the forecast period.
Europe Advanced Wound Care Industry Segmentation
Advanced wound care comprises products that are used to treat acute and chronic wounds, such as ulcers, burns, and post-operative wounds. Advanced wound care products, such as film and foam dressings, hydrogels, alginates, and hydrocolloids keep the wound hydrated for healing without occluding the wound. The Europe Advanced Wound Care Market is segmented by Product (Wound Dressings (Film Dressings, Foams Dressings, Hydrogel Dressings, Collagen Dressings, and Other Dressings), Active Wound Care (Skin Substitutes, and Growth Factors), Therapy Devices (Negative Pressure Wound Therapy, Pressure Relief Devices, Hyperbaric Oxygen Equipment, Compression Therapy, and Other Therapy Devices), and Other Advance Wound Care Products), Wound Type (Chronic Wound (Diabetic Foot Ulcer, Pressure Ulcer, Arterial and Venous Ulcer, and Other Chronic Wound), Acute Wound (Surgical Wounds, Burns, and Other Acute Wounds), and Geography (Germany, United Kingdom, France, Italy, Spain, Rest of Europe). The report offers the value (in USD million) for the above segments.
| By Product | |||||||
| |||||||
| |||||||
| |||||||
| Other Advance Wound Care Products |
| By Wound Type | ||||||
| ||||||
|
| Geography | |
| Germany | |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe |
Europe Advanced Wound Care Market Size Summary
The European advanced wound care market is poised for substantial growth, driven by a combination of factors including the rising prevalence of chronic diseases, an increasing number of surgeries, and a growing geriatric population. The market is expected to experience a healthy expansion over the forecast period, despite challenges posed by the COVID-19 pandemic, which initially disrupted elective surgeries and wound care management. However, government interventions and the critical role of antiseptics in wound treatment have helped mitigate these impacts. The market is further bolstered by the continuous innovation and product launches by key players, such as Advanced Medical Solutions and RLS Global, which are introducing advanced products like Silicone PHMB Foam Dressings and ChloraSolv to enhance wound care protocols.
The demand for advanced wound care products is anticipated to rise, particularly in countries like France, where the prevalence of diabetes and related chronic wounds is increasing. The market's growth is supported by the development of new technologies and products, such as the electrical stimulation wound therapy device Accel-Heal, which facilitates home-based treatment for chronic wounds. Additionally, initiatives like the Circular Foam project aim to reduce raw material costs, further contributing to market expansion. The fragmented nature of the market, with major players like Coloplast AS, Integra Lifesciences, and ConvaTec Group PLC, underscores the competitive landscape, where companies are actively pursuing mergers, acquisitions, and collaborations to strengthen their market presence.
Europe Advanced Wound Care Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Incidences of Chronic Wounds, Ulcers, and Diabetic Ulcers
-
1.2.2 Increase in Volume of Surgical Procedures
-
1.2.3 Rising Geriatric Population
-
-
1.3 Market Restraints
-
1.3.1 Lack of Proper Reimbursements
-
1.3.2 High Treatment Costs
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Wound Dressings
-
2.1.1.1 Film Dressings
-
2.1.1.2 Foams Dressings
-
2.1.1.3 Hydrogel Dressings
-
2.1.1.4 Collagen Dressings
-
2.1.1.5 Other Dressings
-
-
2.1.2 Active Wound Care
-
2.1.2.1 Skin Substitutes
-
2.1.2.2 Growth Factors
-
-
2.1.3 Therapy Devices
-
2.1.3.1 Negative Pressure Wound Therapy
-
2.1.3.2 Pressure Relief Devices
-
2.1.3.3 Hyperbaric Oxygen Equipment
-
2.1.3.4 Compression Therapy
-
2.1.3.5 Other Therapy Devices
-
-
2.1.4 Other Advance Wound Care Products
-
-
2.2 By Wound Type
-
2.2.1 Chronic Wound
-
2.2.1.1 Diabetic Foot Ulcer
-
2.2.1.2 Pressure Ulcer
-
2.2.1.3 Arterial and Venous Ulcer
-
2.2.1.4 Other Chronic Wound
-
-
2.2.2 Acute Wound
-
2.2.2.1 Surgical Wounds
-
2.2.2.2 Burns
-
2.2.2.3 Other Acute Wounds
-
-
-
2.3 Geography
-
2.3.1 Germany
-
2.3.2 United Kingdom
-
2.3.3 France
-
2.3.4 Italy
-
2.3.5 Spain
-
2.3.6 Rest of Europe
-
-
Europe Advanced Wound Care Market Size FAQs
What is the current Europe Advanced Wound Care Market size?
The Europe Advanced Wound Care Market is projected to register a CAGR of 6.10% during the forecast period (2024-2029)
Who are the key players in Europe Advanced Wound Care Market?
Coloplast AS, ConvaTec Group PLC, Smith & Nephew, Integra Lifesciences and Paul Hartmann AG are the major companies operating in the Europe Advanced Wound Care Market.
